{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T06:56:43Z","timestamp":1648623403966},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T00:00:00Z","timestamp":1473033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T00:00:00Z","timestamp":1473033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1038\/bmt.2016.226","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T13:47:26Z","timestamp":1473083246000},"page":"1615-1616","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system"],"prefix":"10.1038","volume":"51","author":[{"given":"P","family":"Anandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Chinian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C R","family":"Cantilena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Dunavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Hensel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Draper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Koklanaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Superata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Muranski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Battiwalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Paczesny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A J","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,5]]},"reference":[{"key":"BFbmt2016226_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1182\/blood-2012-08-355990","volume":"121","author":"S Paczesny","year":"2013","unstructured":"Paczesny S . Discovery and validation of graft-versus-host disease biomarkers. Blood 2013; 121: 585\u2013594.","journal-title":"Blood"},{"key":"BFbmt2016226_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1182\/blood-2014-06-584789","volume":"125","author":"DM Ponce","year":"2015","unstructured":"Ponce DM, Hilden P, Mumaw C, Devlin SM, Lubin M, Giralt S et al. High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation. Blood 2015; 125: 199\u2013205.","journal-title":"Blood"},{"key":"BFbmt2016226_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMoa1213299","volume":"369","author":"MT Vander Lugt","year":"2013","unstructured":"Vander Lugt MT, Braun TM, Hanash S, Ritz J, Ho VT, Antin JH et al. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med 2013; 369: 529\u2013539.","journal-title":"N Engl J Med"},{"key":"BFbmt2016226_CR4","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1182\/blood-2011-08-375006","volume":"118","author":"JL Ferrara","year":"2011","unstructured":"Ferrara JL, Harris AC, Greenson JK, Braun TM, Holler E, Teshima T et al. Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood 2011; 118: 6702\u20136708.","journal-title":"Blood"},{"key":"BFbmt2016226_CR5","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1182\/blood-2008-02-138867","volume":"112","author":"SW Choi","year":"2008","unstructured":"Choi SW, Kitko CL, Braun T, Paczesny S, Yanik G, Mineishi S et al. Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Blood 2008; 112: 1539\u20131542.","journal-title":"Blood"},{"key":"BFbmt2016226_CR6","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2352-3026(14)00035-0","volume":"2","author":"JE Levine","year":"2015","unstructured":"Levine JE, Braun TM, Harris AC, Holler E, Taylor A, Miller H et al. A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study. Lancet Haematol 2015; 2: e21\u2013e29.","journal-title":"Lancet Haematol"},{"key":"BFbmt2016226_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1182\/blood-2014-06-584789","volume":"125","author":"DM Ponce","year":"2014","unstructured":"Ponce DM, Hilden P, Mumaw C, Devlin SM, Lubin M, Giralt S et al. High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation. Blood 2014; 125: 199\u2013205.","journal-title":"Blood"},{"key":"BFbmt2016226_CR8","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.bbmt.2015.01.003","volume":"21","author":"S Paczesny","year":"2015","unstructured":"Paczesny S, Hakim FT, Pidala J, Cooke KR, Lathrop J, Griffith LM et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report. Biol Blood Marrow Transplant 2015; 21: 780\u2013792.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016226_CR9","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/bmt.2015.112","volume":"50","author":"RQ Le","year":"2015","unstructured":"Le RQ, Tian X, Jain NA, Lu K, Ito S, Draper DA et al. Clinical comorbidity predictive measures in ex vivo T-cell-depleted allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2015; 50: 1138\u20131140.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016226_CR10","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912\u20132919.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2016226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016226","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:28:14Z","timestamp":1648063694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2016226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,5]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["BFbmt2016226"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.226","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,5]]},"assertion":[{"value":"5 September 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr SP has a patent on \u2018Methods of detection of graft-versus-host disease\u2019 licensed to Viracor-IBT Laboratories. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}